Effects of Ibudilast on MRI measures in the Phase 2 SPRINT-MS Study
PubMed:
Response to Ibudilast treatment according to progressive multiple sclerosis disease phenotype
PubMed:
Dopamine transporter imaging predicts clinically-defined α-synucleinopathy in REM sleep behavior disorder
PubMed:
Nilotinib in patients with moderately advanced Parkinson Disease: A randomized clinical trial
PubMed:
Safety and Tolerability of SRX246, a Vasopressin 1a Antagonist, in Irritable Huntington’s Disease Patients—A Randomized Phase 2 Clinical Trial
PubMed:
Optical coherence tomography outcomes from the SPRINT-MS trial of Ibudilast in progressive multiple sclerosis
PubMed:
Validation of serum neurofilament light chain as a biomarker of Parkinson's Disease progression.
PubMed:
In vivo distribution of α-synuclein in multiple tissues and biofluids in Parkinson's Disease.
PubMed:
Evolution of Alzheimer's Disease cerebrospinal fluid biomarkers in early Parkinson's Disease.
PubMed:
Neuropsychiatric symptoms and cognitive abilities over the initial quinquennium of Parkinson Disease.
PubMed: